Literature DB >> 27473599

Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history.

Damien Driot1, Bruno Chicoulaa2, Emilie Jouanjus3, Julie Dupouy2, Stéphane Oustric2, Maryse Lapeyre-Mestre3.   

Abstract

This is an addictovigilance report of a pregabalin use disorder case in a young female patient who secondarily presented a tobacco use disorder after smoking initiation combined with pregabalin intake. Pregabalin was first prescribed for anxiety. Concomitant use of pregabalin with tobacco led to a synergic effect of both substances. She presented a craving behavior for pregabalin, with a tolerance phenomenon and a withdrawal syndrome between pregabaline intakes. The patient had a history of depressive disorder, personality disorder and anorexia, but never had any history of substance use disorder. This case report is noteworthy for 3 reasons: 1: this is one of the first report of pregabalin use disorder in a patient without any substance abuse disorder (licit or illicit), with the exception of a personal vulnerability factors to substance abuse; 2: the patient presented characteristics of pregabalin use disorder at usual dose (below 300mg per day), with drug-seeking behavior, tolerance phenomenon and intense craving with these moderate doses; 3: concomitant use of pregabalin with tobacco led to a synergic effect of both substances.
Copyright © 2016 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Addictovigilance; Case reports; Pregabalin; Prégabaline; Présentation de cas; Substance-related disorders; Tobacco use; Troubles liés à une substance; Usage de tabac

Year:  2016        PMID: 27473599     DOI: 10.1016/j.therap.2016.04.006

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  5 in total

1.  Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France.

Authors:  Damien Driot; Emilie Jouanjus; Stéphane Oustric; Julie Dupouy; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

Review 2.  Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review.

Authors:  Rainer Freynhagen; Miroslav Backonja; Stephan Schug; Gavin Lyndon; Bruce Parsons; Stephen Watt; Regina Behar
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

3.  Comparative Study of the Neurotoxic Effects of Pregabalin Versus Tramadol in Rats.

Authors:  Ahmed E Elsukary; Ahmed M N Z Helaly; Amal A El Bakary; Maha E Moustafa; Mohammad A El-Kattan
Journal:  Neurotox Res       Date:  2022-08-17       Impact factor: 3.978

4.  Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.

Authors:  Amneh Al-Husseini; Mayyada Wazaify; Marie Claire Van Hout
Journal:  Int J Ment Health Addict       Date:  2017-09-15       Impact factor: 3.836

5.  Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.

Authors:  Hayahito Ishikawa; Masahiro Takeshima; Hiroyasu Ishikawa; Naoko Ayabe; Hidenobu Ohta; Kazuo Mishima
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.